Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis
- PMID: 36752432
- DOI: 10.1016/j.jcmg.2022.10.018
Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis
Abstract
Background: Sarcoidosis is a complex multisystem inflammatory disorder, with approximately 5% of patients having overt cardiac involvement. Patients with cardiac sarcoidosis are at an increased risk of both ventricular arrhythmias and sudden cardiac death. Previous studies have shown that the presence of late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is associated with an increased risk of mortality and ventricular arrhythmias and may be useful in predicting prognosis.
Objectives: This systematic review and meta-analysis assessed the value of LGE on CMR imaging in predicting prognosis for patients with known or suspected cardiac sarcoidosis.
Methods: The authors searched the Embase and MEDLINE databases from inception to March 2022 for studies reporting individuals with known or suspected cardiac sarcoidosis referred for CMR with LGE. Outcomes were defined as all-cause mortality, ventricular arrhythmia, or a composite outcome of either death or ventricular arrhythmias. The primary analysis evaluated these outcomes according to the presence of LGE. A secondary analysis evaluated outcomes specifically according to the presence of biventricular LGE.
Results: Thirteen studies were included (1,318 participants) in the analysis, with an average participant age of 52.0 years and LGE prevalence of 13% to 70% over a follow-up of 3.1 years. Patients with LGE on CMR vs those without had higher odds of ventricular arrhythmias (odds ratio [OR]: 20.3; 95% CI: 8.1-51.0), all-cause mortality (OR: 3.45; 95% CI: 1.6-7.3), and the composite of both (OR: 9.2; 95% CI: 5.1-16.7). Right ventricular LGE is invariably accompanied by left ventricular LGE. Biventricular LGE is also associated with markedly increased odds of ventricular arrhythmias (OR: 43.6; 95% CI: 16.2-117.2).
Conclusions: Patients with known or suspected cardiac sarcoidosis with LGE on CMR have significantly increased odds of both ventricular arrhythmias and all-cause mortality. The presence of biventricular LGE may confer additional prognostic information regarding arrhythmogenic risk.
Keywords: cardiac magnetic resonance (CMR); cardiac sarcoid; late gadolinium.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Suspected Cardiac Sarcoidosis: Is it Diagnostic or Prognostic? Yes.JACC Cardiovasc Imaging. 2023 Mar;16(3):358-360. doi: 10.1016/j.jcmg.2022.11.022. Epub 2023 Jan 11. JACC Cardiovasc Imaging. 2023. PMID: 36752435 No abstract available.
Similar articles
-
Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.Circ Cardiovasc Imaging. 2016 Sep;9(9):e005001. doi: 10.1161/CIRCIMAGING.116.005001. Circ Cardiovasc Imaging. 2016. PMID: 27621357 Free PMC article.
-
Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.JACC Cardiovasc Imaging. 2017 Apr;10(4):411-420. doi: 10.1016/j.jcmg.2016.05.009. Epub 2016 Jul 20. JACC Cardiovasc Imaging. 2017. PMID: 27450877 Free PMC article.
-
"Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.J Cardiovasc Electrophysiol. 2023 Aug;34(8):1781-1784. doi: 10.1111/jce.16020. Epub 2023 Jul 26. J Cardiovasc Electrophysiol. 2023. PMID: 37493490
-
CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.JACC Cardiovasc Imaging. 2013 Apr;6(4):501-11. doi: 10.1016/j.jcmg.2012.10.021. Epub 2013 Mar 14. JACC Cardiovasc Imaging. 2013. PMID: 23498675
-
Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.Eur Radiol. 2020 Jul;30(7):3702-3710. doi: 10.1007/s00330-020-06765-1. Epub 2020 Mar 12. Eur Radiol. 2020. PMID: 32166494
Cited by
-
Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review.Eur Heart J Cardiovasc Imaging. 2023 Sep 26;24(10):1302-1317. doi: 10.1093/ehjci/jead124. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37267310 Free PMC article. Review.
-
Cardiac Sarcoidosis: A Comprehensive Clinical Review.Rev Cardiovasc Med. 2024 Jan 29;25(2):37. doi: 10.31083/j.rcm2502037. eCollection 2024 Feb. Rev Cardiovasc Med. 2024. PMID: 39077350 Free PMC article. Review.
-
Cardiac Sarcoidosis-Diagnostic and Therapeutic Challenges.J Clin Med. 2024 Mar 15;13(6):1694. doi: 10.3390/jcm13061694. J Clin Med. 2024. PMID: 38541919 Free PMC article. Review.
-
CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction.Eur Heart J Cardiovasc Imaging. 2024 Oct 30;25(11):1491-1504. doi: 10.1093/ehjci/jeae224. Eur Heart J Cardiovasc Imaging. 2024. PMID: 39205602 Free PMC article. Review.
-
Complete heart block as the first manifestation of systemic sarcoidosis: a case report highlighting the diagnostic utility of multimodality imaging.Eur Heart J Case Rep. 2025 Apr 29;9(5):ytaf210. doi: 10.1093/ehjcr/ytaf210. eCollection 2025 May. Eur Heart J Case Rep. 2025. PMID: 40336939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical